KR960700722A - Fibrinogen receptor antagonists - Google Patents
Fibrinogen receptor antagonistsInfo
- Publication number
- KR960700722A KR960700722A KR1019950703563A KR19950703563A KR960700722A KR 960700722 A KR960700722 A KR 960700722A KR 1019950703563 A KR1019950703563 A KR 1019950703563A KR 19950703563 A KR19950703563 A KR 19950703563A KR 960700722 A KR960700722 A KR 960700722A
- Authority
- KR
- South Korea
- Prior art keywords
- receptor antagonists
- fibrinogen receptor
- fibrinogen
- antagonists
- receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A61K38/166—Streptokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2051793A | 1993-02-22 | 1993-02-22 | |
| PCT/US1994/001881 WO1994018981A1 (en) | 1993-02-22 | 1994-02-22 | Fibrinogen receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR960700722A true KR960700722A (en) | 1996-02-24 |
Family
ID=21799049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019950703563A KR960700722A (en) | 1993-02-22 | 1995-08-21 | Fibrinogen receptor antagonists |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0684823A4 (en) |
| JP (1) | JP3173792B2 (en) |
| KR (1) | KR960700722A (en) |
| CN (1) | CN1118139A (en) |
| AU (1) | AU680240B2 (en) |
| BG (1) | BG99863A (en) |
| CA (1) | CA2155123A1 (en) |
| CZ (1) | CZ210895A3 (en) |
| FI (1) | FI953916A0 (en) |
| HU (1) | HUT71796A (en) |
| NO (1) | NO953270L (en) |
| NZ (1) | NZ262664A (en) |
| PL (1) | PL310386A1 (en) |
| SK (1) | SK102495A3 (en) |
| WO (1) | WO1994018981A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
| US5494921A (en) * | 1994-09-16 | 1996-02-27 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| ZA963391B (en) * | 1995-05-24 | 1997-10-29 | Du Pont Merck Pharma | Isoxazoline fibrinogen receptor antagonists. |
| CA2230209A1 (en) * | 1995-08-30 | 1997-03-06 | G.D. Searle & Co. | Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| US6100423A (en) * | 1995-08-30 | 2000-08-08 | G. D. Searle & Co. | Amino benzenepropanoic acid compounds and derivatives thereof |
| EP0854869B1 (en) | 1995-09-29 | 2004-08-25 | Eli Lilly And Company | Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| CA2240439A1 (en) * | 1995-12-22 | 1997-07-03 | The Dupont Merck Pharmaceutical Company | Novel integrin receptor antagonists |
| AU2340997A (en) * | 1996-03-27 | 1997-10-17 | Merck & Co., Inc. | A method for inhibiting clot formation |
| EP0917462B1 (en) * | 1996-07-25 | 2006-09-13 | Biogen Idec MA Inc. | Cell adhesion inhibitors |
| US5900414A (en) * | 1996-08-29 | 1999-05-04 | Merck & Co., Inc. | Methods for administering integrin receptor antagonists |
| DE19653647A1 (en) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Vitronectin receptor antagonists, their preparation and their use |
| CA2279927A1 (en) * | 1997-02-06 | 1998-08-13 | Merck & Co., Inc. | Fibrinogen receptor antagonist prodrugs |
| WO1998043962A1 (en) * | 1997-03-28 | 1998-10-08 | Du Pont Pharmaceuticals Company | Heterocyclic integrin inhibitor prodrugs |
| US6303625B1 (en) * | 1998-07-27 | 2001-10-16 | Ortho-Mcneil Pharmaceutical, Inc. | Triazolopyridines for the treatment of thrombosis disorders |
| DE60041584D1 (en) * | 1999-07-28 | 2009-04-02 | Aventis Pharma Inc | SUBSTITUTED OXOAZAHETEROZYCLIC COMPOUNDS |
| AU2003297431A1 (en) * | 2002-12-20 | 2004-07-22 | Pharmacia Corporation | Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds |
| WO2008006540A1 (en) * | 2006-07-12 | 2008-01-17 | Syngenta Participations Ag | Triazolopyridine derivatives as herbicides |
| WO2009137201A1 (en) * | 2008-04-04 | 2009-11-12 | Cv Therapeutics, Inc. | Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors |
| WO2010096722A1 (en) * | 2009-02-20 | 2010-08-26 | Takeda Pharmaceutical Company Limited | 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
| GB8913011D0 (en) * | 1989-06-06 | 1989-07-26 | Wellcome Found | Anticonvulsant pyrazines |
| US5166154A (en) * | 1989-10-17 | 1992-11-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | Imidazo[1,2-a]piperazines |
| US5278161A (en) * | 1990-06-28 | 1994-01-11 | Hoffmann-La Roche Inc. | Amino acid derivatives useful as renin inhibitors |
-
1994
- 1994-02-22 WO PCT/US1994/001881 patent/WO1994018981A1/en not_active Application Discontinuation
- 1994-02-22 EP EP94909745A patent/EP0684823A4/en not_active Withdrawn
- 1994-02-22 JP JP51922094A patent/JP3173792B2/en not_active Expired - Fee Related
- 1994-02-22 PL PL94310386A patent/PL310386A1/en unknown
- 1994-02-22 AU AU62465/94A patent/AU680240B2/en not_active Ceased
- 1994-02-22 CA CA002155123A patent/CA2155123A1/en not_active Abandoned
- 1994-02-22 CZ CZ952108A patent/CZ210895A3/en unknown
- 1994-02-22 SK SK1024-95A patent/SK102495A3/en unknown
- 1994-02-22 NZ NZ262664A patent/NZ262664A/en unknown
- 1994-02-22 CN CN94191248A patent/CN1118139A/en active Pending
- 1994-02-22 HU HU9502028A patent/HUT71796A/en unknown
-
1995
- 1995-08-15 BG BG99863A patent/BG99863A/en unknown
- 1995-08-21 FI FI953916A patent/FI953916A0/en not_active Application Discontinuation
- 1995-08-21 KR KR1019950703563A patent/KR960700722A/en not_active Application Discontinuation
- 1995-08-21 NO NO953270A patent/NO953270L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1118139A (en) | 1996-03-06 |
| NZ262664A (en) | 1997-04-24 |
| WO1994018981A1 (en) | 1994-09-01 |
| AU680240B2 (en) | 1997-07-24 |
| BG99863A (en) | 1996-02-29 |
| HU9502028D0 (en) | 1995-09-28 |
| CZ210895A3 (en) | 1996-02-14 |
| HUT71796A (en) | 1996-02-28 |
| NO953270L (en) | 1995-10-19 |
| AU6246594A (en) | 1994-09-14 |
| EP0684823A4 (en) | 1997-07-09 |
| PL310386A1 (en) | 1995-12-11 |
| NO953270D0 (en) | 1995-08-21 |
| CA2155123A1 (en) | 1994-09-01 |
| SK102495A3 (en) | 1997-01-08 |
| JP3173792B2 (en) | 2001-06-04 |
| JPH08507072A (en) | 1996-07-30 |
| FI953916A (en) | 1995-08-21 |
| FI953916A0 (en) | 1995-08-21 |
| EP0684823A1 (en) | 1995-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69207351T2 (en) | Fibrinogen receptor antagonists | |
| GB9405317D0 (en) | Fibrinogen receptor antagonists | |
| FI961804A0 (en) | endothelin receptor antagonists | |
| MX9101311A (en) | FIBRINOGEN RECEPTOR ANTAGONISTS | |
| DE69530571D1 (en) | BICYCLIC FIBRINOGEN ANTAGONISTS | |
| EP0673247A4 (en) | Fibrinogen receptor antagonists. | |
| EP0667773A4 (en) | Fibrinogen receptor antagonists. | |
| AU1441695A (en) | Fibrinogen receptor antagonists | |
| AU3665793A (en) | Fibrinogen receptor antagonists | |
| EP0810994A4 (en) | Fibrinogen receptor antagonists | |
| EP0866705A4 (en) | Fibrinogen receptor antagonists | |
| KR960700722A (en) | Fibrinogen receptor antagonists | |
| DK0699069T3 (en) | endothelin receptor antagonists | |
| KR950703530A (en) | 5-HT4 Antagonists | |
| EP0801650A4 (en) | Fibrinogen receptor antagonists | |
| AU5322994A (en) | Fibrinogen receptor antagonists | |
| NO179550C (en) | Tachykinin receptor antagonists | |
| GB9320799D0 (en) | Fibrinogen receptor antagonists | |
| EP0794779A4 (en) | Fibrinogen receptor antagonists | |
| GB9515852D0 (en) | Fibrinogen receptor antagonists | |
| EP0800395A4 (en) | Fibrinogen receptor antagonists | |
| EP0781133A4 (en) | Fibrinogen receptor antagonists | |
| LV10425A (en) | Fibrinogen receptor antagonists | |
| ZA917693B (en) | Fibrinogen receptor antagonists | |
| GB9516643D0 (en) | Fibrinogen receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |